Stock Events

Stock Events

Search...

Allogene Therapeutics (ALLO) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.35

-0.33

-0.3

-0.28

Details

Expected EPS

-0.290467

Actual EPS

-0.28

Surprise EPS

0.01

Surprise Percent

+3.6%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.28 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.